9iul

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (04:59, 18 September 2024) (edit) (undo)
 
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 9iul is ON HOLD
+
==The structure of Candida albicans Cdr1 in fluconazole-bound state==
 +
<StructureSection load='9iul' size='340' side='right'caption='[[9iul]], [[Resolution|resolution]] 3.30&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[9iul]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Candida_albicans_SC5314 Candida albicans SC5314]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9IUL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9IUL FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.3&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1L26:[(2~{R})-2-octadecanoyloxy-3-[oxidanyl-[(1~{S},2~{R},3~{S},4~{S},5~{S},6~{R})-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl]+(5~{E},8~{E},11~{E},14~{E})-icosa-5,8,11,14-tetraenoate'>A1L26</scene>, <scene name='pdbligand=TPF:2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL'>TPF</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9iul FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9iul OCA], [https://pdbe.org/9iul PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9iul RCSB], [https://www.ebi.ac.uk/pdbsum/9iul PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9iul ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/CDR1_CANAL CDR1_CANAL] Pleiotropic ABC efflux transporter that confers resistance to numerous chemicals including anisomycin, cycloheximide, fluconazole, miconazole, ketoconazole, itriconazole, nystatin, terbinafine, amorolfine, brefeldin A, amphotericin B, fluphenazine, as well as estrogen. Plays a role in farnesol-induced apoptotic process through glutathione efflux activity. Mediates in-to-out translocation of membrane phospholipids including aminophospholipids and thus regulates asymmetric distribution of phosphatidylethanolamine. Exhibits nucleoside triphosphatase activity.<ref>PMID:10029989</ref> <ref>PMID:10227177</ref> <ref>PMID:10428921</ref> <ref>PMID:11709310</ref> <ref>PMID:11870854</ref> <ref>PMID:12709320</ref> <ref>PMID:14665469</ref> <ref>PMID:15152937</ref> <ref>PMID:15190023</ref> <ref>PMID:15486081</ref> <ref>PMID:15937063</ref> <ref>PMID:16291868</ref> <ref>PMID:16475832</ref> <ref>PMID:16622073</ref> <ref>PMID:16782311</ref> <ref>PMID:17202662</ref> <ref>PMID:18056285</ref> <ref>PMID:18268086</ref> <ref>PMID:18710914</ref> <ref>PMID:19223631</ref> <ref>PMID:19393219</ref> <ref>PMID:20002912</ref> <ref>PMID:20348384</ref> <ref>PMID:20876623</ref> <ref>PMID:22166216</ref> <ref>PMID:22205973</ref> <ref>PMID:23824183</ref> <ref>PMID:23979757</ref> <ref>PMID:8891134</ref> <ref>PMID:9124851</ref> <ref>PMID:9453158</ref> <ref>PMID:9605504</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
In Candida albicans, Cdr1 pumps azole drugs out of the cells to reduce intracellular accumulation at detrimental concentrations, leading to azole-drug resistance. Milbemycin oxime, a veterinary anti-parasitic drug, strongly and specifically inhibits Cdr1. However, how Cdr1 recognizes and exports azole drugs, and how milbemycin oxime inhibits Cdr1 remain unclear. Here, we report three cryo-EM structures of Cdr1 in distinct states: the apo state (Cdr1(Apo)), fluconazole-bound state (Cdr1(Flu)), and milbemycin oxime-inhibited state (Cdr1(Mil)). Both the fluconazole substrate and the milbemycin oxime inhibitor are primarily recognized within the central cavity of Cdr1 through hydrophobic interactions. The fluconazole is suggested to be exported from the binding site into the environment through a lateral pathway driven by TM2, TM5, TM8 and TM11. Our findings uncover the inhibitory mechanism of milbemycin oxime, which inhibits Cdr1 through competition, hindering export, and obstructing substrate entry. These discoveries advance our understanding of Cdr1-mediated azole resistance in C. albicans and provide the foundation for the development of innovative antifungal drugs targeting Cdr1 to combat azole-drug resistance.
-
Authors:
+
Cryo-EM structures of Candida albicans Cdr1 reveal azole-substrate recognition and inhibitor blocking mechanisms.,Peng Y, Lu Y, Sun H, Ma J, Li X, Han X, Fang Z, Tan J, Qiu Y, Qu T, Yin M, Yan Z Nat Commun. 2024 Sep 6;15(1):7722. doi: 10.1038/s41467-024-52107-w. PMID:39242571<ref>PMID:39242571</ref>
-
Description:
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[Category: Unreleased Structures]]
+
</div>
 +
<div class="pdbe-citations 9iul" style="background-color:#fffaf0;"></div>
 +
== References ==
 +
<references/>
 +
__TOC__
 +
</StructureSection>
 +
[[Category: Candida albicans SC5314]]
 +
[[Category: Large Structures]]
 +
[[Category: Peng Y]]
 +
[[Category: Sun H]]
 +
[[Category: Yan ZF]]

Current revision

The structure of Candida albicans Cdr1 in fluconazole-bound state

PDB ID 9iul

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/9iul"
Personal tools